Increasing nontuberculous mycobacteria infection in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 14, Issue 1, 2015, Pages 53-62

  Bar On, Ophir ^a   Mussaffi, Huda ^a,b   Mei Zahav, Meir ^a,b   Prais, Dario ^a,b   Steuer, Guy ^a   Stafler, Patrick ^a,b   Hananya, Shai ^a   Blau, Hannah ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Allergic bronchopulmonary aspergillosis; Cystic fibrosis; Mycobacterium abscessus; Nontuberculous mycobacteria

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CYTOKINE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PANCREAS ENZYME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BLOOD LEVEL; CHILD; CHRONIC LUNG DISEASE; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION RATE; LABORATORY DIAGNOSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PANCREAS FUNCTION; PREVALENCE; PSEUDOMONAS INFECTION; SPUTUM CULTURE; TREATMENT DURATION; AGE DISTRIBUTION; COMORBIDITY; COMPARATIVE STUDY; ISOLATION AND PURIFICATION; ISRAEL; LONGITUDINAL STUDY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONPARAMETRIC TEST; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; HUMANS; ISRAEL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84918788968     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.05.008     Document Type: Article

References (30)

1. Zemanick E.T., Sagel S.D., Harris J.K. The airway microbiome in cystic fibrosis and implications for treatment. Curr Opin Pediatr 2011, 23:319-324.
2. Boxerbaum B. Isolation of rapidly growing mycobacteria in patients with cystic fibrosis. J Pediatr 1980, 96:689-691.
3. Smith M.J., Efthimiou J., Hodson M.E., Batten J.C. Mycobacterial isolation in young adults with cystic fibrosis. Thorax 1984, 39:369-375.
4. Olivier K.N., Weber D.J., Wallace R.J., Faiz A.R., Lee J.H., Zhang Y., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:828-834.
5. Kendall B.A., Winthrop K.L. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med 2013, 34:87-94.
6. Roux A.L., Catherinot E., Ripoll F., Soismier N., Macheras E., Ravilly S., et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 2009, 47:4124-4128.
7. Radhakrishnan D.K., Yau Y., Corey M., Richardson S., Chedore P., Jamieson F., et al. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol 2009, 44:1100-1106.
8. Hill U.G., Floto R.A., Haworth C.S. Non-tuberculous mycobacteria in cystic fibrosis. J R Soc Med 2012, 105(Suppl. 2):S14-S18.
9. Levy I., Grisaru-Soen G., Lerner-Geva L., Kerem E., Blau H., Bentur L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008, 14:378-384.
10. Falkinham J.O. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 2009, 107:356-367.
11. Mussaffi H., Rivlin J., Shalit I., Ephros M., Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005, 25:324-328.
12. Sermet-Gaudelus I., Le Bourgeois M., Pierre-Audigier C., Offredo C., Guillemot D., Halley S., et al. Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 2003, 9:1587-1591.
13. Stout J.E. Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections. Expert Rev Anti Infect Ther 2006, 4:981-993.
14. Bryant J.M., Grogono D.M., Greaves D., Foweraker J., Roddick I., Inns T., et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013, 381:1551-1560.
15. Sexton P., Harrison A.C. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 2008, 31:1322-1333.
16. Chan E., Chan E.D., Bai X., Kartalija M., Orme I.M., Ordway D.J. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease. Am J Respir Cell Mol Biol 2010, 43:387-393.
17. Holland S.M. Host defense against nontuberculous mycobacterial infections. Semin Respir Infect 1996, 11:217-230.
18. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 2008, 153:S4-S14.
19. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
20. Fujita J., Ohtsuki Y., Suemitsu I., Shigeto E., Yamadori I., Obayashi Y., et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J 1999, 13:535-540.
21. Weiss C.H., Glassroth J. Pulmonary disease caused by nontuberculous mycobacteria. Expert Rev Respir Med 2012, 6:597-612.
22. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
23. Green D.M., McDougal K.E., Blackman S.M., Sosnay P.R., Henderson L.B., Naughton K.M., et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res 2010, 11:140-149.
24. ECFS Patient Registry Annual Data Report 2008-2009 data Date last updated: June, [Date last accessed: August 4, 2013]. http://www.cysticfibrosisdata.org/LiteratureRetrieve.aspx?ID=132593.
25. UK CF Registry Annual Data Report [Date last updated: January 2013. Date last accessed: August 4, 2013]. https://www.cysticfibrosis.org.uk/media/82506/CR_Annual_Data_Report_2011_Jan_13.pdf.
26. Catherinot E., Roux A.L., Vibet M.A., Bellis G., Ravilly S., Lemonnier L., et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 2013, 12:74-80.
27. Paugam A., Baixench M.T., Demazes-Dufeu N., Burgel P.R., Sauter E., Kanaan R., et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 2010, 48(Suppl. 1):S32-S36.
28. Jeon B.Y., Kwak J., Lee S.S., Cho S., Won C.J., Kim J.M., et al. Comparative analysis of immune responses to Mycobacterium abscessus infection and its antigens in two murine models. J Microbiol 2009, 47:633-640.
29. Sampaio E.P., Elloumi H.Z., Zelazny A., Ding L., Paulson M.L., Sher A., et al. Mycobacterium abscessus and M. avium trigger toll-like receptor 2 and distinct cytokine response in human cells. Am J Respir Cell Mol Biol 2008, 39:431-439.
30. Hoefsloot W., van Ingen J., Andrejak C., Angeby K., Bauriaud R., Bemer P., et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: a NTM-NET collaborative study. Eur Respir J 2013, 42(6):1604-1613. for NTM-NET (www.ntm-net.org).